Substance use including opioids, methamphetamines, benzodiazepines, and barbiturates during pregnancy is harmful for the pregnant person and the fetus. Routine screening using validated questionnaires is recommended, but often biologic sampling is done instead. There is often bias in urine drug screening on labor and delivery units.
This is a retrospective chart review examining all people in 2017 who delivered on the labor and delivery unit at our institution. We collected urine drug screening result information, maternal demographic data, follow up after positive maternal tests, and neonatal test results. Individual characteristics and obstetric outcomes were analyzed.